MOTS-c and SS-31 Interaction
MOTS-c and SS-31 have a synergistic interaction with 95% confidence. Both are mitochondrial peptides with complementary mechanisms. Both compounds affect the pancreas, so monitoring these systems is recommended.
Compound Profiles
MOTS-c
Mitochondrial-Derived Peptide | Metabolic Regulator
Inhibits the folate cycle leading to AMPK activation. Under metabolic stress, translocates to nucleus to bind stress-response transcription factors, regulating genes involved in metabolism, insulin sensitivity, and cellular adaptation.
View full profileSS-31
Mitochondrial-Targeted Peptide | Cardiolipin Protector
Selectively binds to cardiolipin in inner mitochondrial membrane, preventing lipid peroxidation and optimizing electron transport chain function. This improves ATP production and reduces oxidative damage at the mitochondrial level.
View full profileCombined Organ Load
Shared Safety Flags
Frequently Asked Questions
Can I take MOTS-c with SS-31?
Yes, MOTS-c and SS-31 can generally be taken together. Both are mitochondrial peptides with complementary mechanisms.
Is MOTS-c and SS-31 safe together?
Based on documented research, this combination is considered synergistic. However, shared safety flags include: teratogenic. Monitor accordingly.
What are the interactions between MOTS-c and SS-31?
Both are mitochondrial peptides with complementary mechanisms. This assessment has 95% confidence and is based on documented research data.
How should I time MOTS-c and SS-31?
MOTS-c has a half-life of ~30 minutes and SS-31 has a half-life of ~2 hours. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.
This interaction analysis is compiled from research literature and pharmacological mechanism data. Always consult a healthcare professional before combining compounds.